| Literature DB >> 25438057 |
Abstract
As the US addresses its budget dilemma, the easiest items to cut are those with the longest-term payoff. Research stands out among this group. Biomedical research has already been markedly reduced, and further reductions appear to be in store. As a frequent witness in Congressional hearings on such matters, here I discuss the challenge of assessing the value of investments in biomedical research.Mesh:
Year: 2014 PMID: 25438057 PMCID: PMC4348965 DOI: 10.1172/JCI79617
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808